USX:DRIO - DarioHealth Corp (USD 6.577) DarioHealth Corp
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   


Yahoo Finance

USD 6.5775    +0.628 (+10.55%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


Overview

9 Apr 2020

Day Change: 0.628 (10.55%)

52 Wk Range: 0.2 - 11.25

Day's Range: 5.6 - 6.6562

Last Volume: 12,031

Current Yield: 0%

Projected Yield: 0%

Open: USD 5.93

9 Apr 2020

Metric DRIO S.Median
Beta 0.86 0.84
VaR 741.96 25.23
E.Shortfall 741.96 45.03
Liquidity 12.82K 95.2K

Fundamental

9 Apr 2020

PE: 0.964

Market Cap: -17.1M

Price Over Book: -0.905

Price Over Sales: -2.26

Return On Assets: -72.2%

Return On Equity: -93.9%

Price Over NAV: [Friends Only]

General

CEO: Erez Raphael

Headquarters: CAESAREA

Employees: 69

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. Its flagship product is Dario Smart Diabetes Management Solution, a mobile, real-time, cloud-based, diabetes management solution based on a multi-feature software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. The company is also pursuing patent applications in various jurisdictions covering the specific processes related to blood glucose level measurement, as well as various general methods of rapid tests of body fluids using mobile devices and cloud-based services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. The company was founded in 2011 and is headquartered in Caesarea, Israel.